Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 25 days ago
, as articulated in the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our Mission is to
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 9 hours ago
, as articulated in the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our Mission is to
-
position is immediately available to develop an immunotherapy to treat HIV/Mtb co-infection. In addition, the prospective candidate will also participate in a phage therapy project that aims to develop a
-
evaluating a novel digital health intervention to support self-management and care of people receiving immunotherapy for cancer. Immunotherapy has revolutionised treatment for certain cancers. However, in many
-
available under the project: Project 101220473. NEXT-CRC (ERC-2025-STG) (HORIZON-ERC) (ERCEA/C/04) “Next-generation colorectal cancer microecosystems for the discovery of microbiome-driven immunotherapies in
-
Position Summary A postdoctoral (Ph.D. or M.D./Ph.D.) opportunity to study myeloid cell biology and its implications for immunotherapy is available to join the laboratory of Dr. Eynav Klechevsky
-
proteins, etc.) to target various chemoattractants to sites of tumor, using these alone and in combination with other strategies for immunomodulation. A second focus of the lab is translational immunotherapy
-
discover how we can advance health together. Duke Health Integrated Practice https://careers.dukehealth.org/us/en/dhip Duke Health Integrated Practice comprises more than 110 primary and specialty outpatient
-
to immunotherapies for type 1 diabetes as well as somatic variants in the pancreas and immune cells of organ donors with type 1 diabetes. For more information on the Shapiro Laboratory please visit here: https
-
Research Assistant/Associate in the safer management of long-term conditions (LTCs) in disadvantaged
effects of, novel anti-cancer medicines (eg immunotherapy): and (iii) inequalities in mental health and other long-term conditions, including poor oral health outcomes. You will have an opportunity to get